Publications by authors named "Francisca Cuenca"

Claim this Profile
G
Genetic map of Wilson disease in Spain - A great tool to improve diagnosis and screening.
Pablo Alonso-Castellano, Zoe Mariño, Antonio Tugores, Antonio Olveira, Javier Ampuero, Francisca Cuenca

Rev Esp Enferm Dig· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproductive and pregnancy control in Wilson disease patients in Spain.
Marta Romero-Gutiérrez, Pablo Alonso, Marina Berenguer, Antonio Olveira, María Luisa González-Diéguez, Francisca Cuenca

Eur J Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study.
Ana Barreira-Díaz, Mar Riveiro-Barciela, Eva María Fernández-Bonilla, Vanesa Bernal, Agustín Castiella, Francisca Cuenca

Ann Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C.
Leire Pérez-Latorre, Antonio Rivero-Juárez, Víctor Hontañón, Cristina Díez, Francisca Cuenca

Open Forum Infect Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Therapeutic update in hepatitis C].
María José Devesa, Francisca Cuenca, Sonia Izquierdo, Pilar Sánchez-Pobre, José María Ladero

Rev Esp Quimioter· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.
José M Ladero, María J Torrejón, Pilar Sánchez-Pobre, Avelina Suárez, Francisca Cuenca

Ann Hepatol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C? .
José M Ladero, María C Cárdenas, Luis Ortega, Andrea González-Pino, Francisca Cuenca

Ann Hepatol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease.
José A Agúndez, Elena García-Martin, María L Maestro, Francisca Cuenca, Carmen Martínez

PLoS One· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods.
José M Ladero, Jaime Delkader, Luis Ortega, Cristina Fernández, María J Devesa, Francisca Cuenca

Scand J Gastroenterol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"12 weeks' stopping rule" in the treatment of genotype 1 chronic hepatitis C: two prognostic categories under the same label?
José M Ladero, Gustavo López-Alonso, María J Devesa, Francisca Cuenca, Marta Agreda

Scand J Gastroenterol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis